Inventor · disambiguated record
Mani Bushan Kotala
Also filed as: KOTALA MANI BUSHAN
10 granted patents·2 pending applications·23 citations·filing 2015–2024
83Inventor score
Files withNuCana plc7ELOXOX PHARMACEUTICALS LTD1ELOXX PHARMACEUTICALS LTD1LAURUS LABS LTD1LAURUS LABS PRIVATE LTD1
Top patents by PatentIndex Score
12 records- 0187US9834577B2Process for the preparation of gemcitabine-[phenyl(benzoxy-L-alaninyl)] phosphateNUCANA BIOMED LTD·Filed 2015·Granted Dec 5, 2017·17 cites·19 claims
- 0286US10774104B2Diastereoselective synthesis of phosphate derivativesNuCana plc·Filed 2016·Granted Sep 15, 2020·4 cites·26 claims
- 0384US2025171487A1Synthesis of phosphate derivativesNuCana plc·Filed 2024·Application pending·0 cites
- 0480US11414452B2Synthesis of phosphate derivativesNuCana plc·Filed 2018·Granted Aug 16, 2022·1 cites·7 claims
- 0579US12054511B2Synthesis of phosphate derivativesNuCana plc·Filed 2022·Granted Aug 6, 2024·0 cites·26 claims
- 0675US11414451B2Floxuridine synthesisNuCana plc·Filed 2018·Granted Aug 16, 2022·1 cites·32 claims
- 0765US11897913B2Synthesis of 3′-deoxyadenosine-5′-O-[phenyl(benzyloxy-L-alaninyl)]phosphate (NUC-738)NuCana plc·Filed 2018·Granted Feb 13, 2024·0 cites·8 claims
- 0865US11603382B2Diastereoselective synthesis of phosphate derivativesNuCana plc·Filed 2020·Granted Mar 14, 2023·0 cites·23 claims
- 0958US10301321B2Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereofLAURUS LABS LTD·Filed 2017·Granted May 28, 2019·0 cites·21 claims
- 1057US2022033428A1Large scale preparation of pseudo-trisaccharide aminoglycosides and of intermediates thereofELOXOX PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1150US11136345B2Large scale preparation of pseudo-trisaccharide aminoglycosides and of intermediates thereofELOXX PHARMACEUTICALS LTD·Filed 2018·Granted Oct 5, 2021·0 cites·14 claims
- 1247US9856271B2Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereofLAURUS LABS PRIVATE LTD·Filed 2015·Granted Jan 2, 2018·0 cites·29 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →